Synopsis
Synopsis
0
VMF
0
Canada
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 5 Formyltetrahydrofolate
2. 5 Formyltetrahydropteroylglutamate
3. 5-formyltetrahydrofolate
4. 5-formyltetrahydropteroylglutamate
5. Acid, Folinic
6. Calcium Folinate
7. Citrovorum Factor
8. Factor, Citrovorum
9. Folinate, Calcium
10. Folinic Acid
11. Folinic Acid Sf
12. Folinic Acid-sf
13. Leucovorin
14. Leucovorin, (d)-isomer
15. Leucovorin, (dl)-isomer
16. Leucovorin, (r)-isomer
17. Leucovorin, Calcium
18. Leucovorin, Calcium (1:1) Salt
19. Leucovorin, Calcium (1:1) Salt, (dl)-isomer
20. Leucovorin, Calcium (1:1) Salt, Pentahydrate
21. Leucovorin, Monosodium Salt
22. Leukovorin
23. Leukovorum
24. Monosodium Salt Leucovorin
25. N(5)-formyltetrahydrofolate
26. Wellcovorin
1. Calcium Folinate
2. Calcium Citrovorum Factor
3. Folinic Acid Calcium Salt
4. Folinic Acid-sf, Calcium Salt
5. (+)-l-folinic Acid, Calcium Salt
6. 1492-18-8
7. Nsc3590
8. Sr-05000001662
9. Pharmakon1600-01500364
10. Nsc757083
11. Nsc-757083
12. Sr-05000001662-1
13. Sr-05000001662-2
14. Glutamic Acid,6,7,8-tetrahydro-4-hydroxy-6- Pteridinyl)methyl]amino]benzoyl]-, Calcium Salt (1:1), L-
15. L-glutamic Acid,4,5,6,7,8-hexahydro-4-oxo-6- Pteridinyl)methyl]amino]benzoyl]-, Calcium Salt (1:1), (s)-
Molecular Weight | 513.5 g/mol |
---|---|
Molecular Formula | C20H23CaN7O7+2 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 9 |
Exact Mass | 513.1284869 g/mol |
Monoisotopic Mass | 513.1284869 g/mol |
Topological Polar Surface Area | 216 Ų |
Heavy Atom Count | 35 |
Formal Charge | 2 |
Complexity | 911 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antidotes
Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)
Vitamin B Complex
A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)
V - Various
V03 - All other therapeutic products
V03A - All other therapeutic products
V03AF - Detoxifying agents for antineoplastic treatment
V03AF03 - Calcium folinate
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-10-18
Pay. Date : 2024-09-19
DMF Number : 40427
Submission : 2024-09-04
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-07-26
Pay. Date : 2024-06-10
DMF Number : 38878
Submission : 2023-09-27
Status : Active
Type : II
Certificate Number : R1-CEP 2011-370 - Rev 00
Issue Date : 2019-07-26
Type : Chemical
Substance Number : 978
Status : Valid
NDC Package Code : 63660-0012
Start Marketing Date : 2012-10-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-03-02
Pay. Date : 2018-02-20
DMF Number : 5261
Submission : 1984-01-23
Status : Active
Type : II
Certificate Number : R1-CEP 1996-055 - Rev 08
Issue Date : 2023-05-19
Type : Chemical
Substance Number : 978
Status : Valid
Registration Number : 218MF10352
Registrant's Address : Weisshausmatte CH-6460 Altdorf Switzerland
Initial Date of Registration : 2006-03-17
Latest Date of Registration : --
NDC Package Code : 54784-009
Start Marketing Date : 1984-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Wooshin Labotech Co., Ltd.
Registration Date : 2021-04-05
Registration Number : 20210405-210-J-686
Manufacturer Name : Merck & Cie KmG@Dottikon Exclusive Synthesis AG
Manufacturer Address : Im Laternenacker 5,CH-8200 Schaffhausen, Switzerland@Hembrunnstrasse 17 CH-5605 Dottikon Switzerland
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-08-16
Pay. Date : 2019-06-24
DMF Number : 33740
Submission : 2019-05-18
Status : Active
Type : II
NDC Package Code : 68034-100
Start Marketing Date : 2019-05-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-10-04
Pay. Date : 2013-09-25
DMF Number : 5046
Submission : 1983-06-30
Status : Active
Type : II
Certificate Number : CEP 1997-051 - Rev 10
Issue Date : 2024-03-06
Type : Chemical
Substance Number : 978
Status : Valid
Registration Number : 221MF10021
Registrant's Address : Via Figino 6,6917 Barbengo/Lugano, Switzerland
Initial Date of Registration : 2009-01-28
Latest Date of Registration : --
NDC Package Code : 54239-002
Start Marketing Date : 1983-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2022-01-05
Registration Number : 20220105-210-J-1193
Manufacturer Name : Cerbios pharma SA
Manufacturer Address : Via Figino 6, 6917 Barbengo/Lugano, Switzerland
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25334
Submission : 2011-08-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16718
Submission : 2003-07-18
Status : Inactive
Type : II
Certificate Number : CEP 2004-009 - Rev 04
Issue Date : 2024-04-15
Type : Chemical
Substance Number : 978
Status : Valid
Registration Number : 227MF10147
Registrant's Address : 6, rue des Iles CH-2108 COUVET Switzerland
Initial Date of Registration : 2015-05-20
Latest Date of Registration : --
NDC Package Code : 68034-100
Start Marketing Date : 2019-05-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3715
Submission : 1980-02-11
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5429
Submission : 1984-07-09
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25334
Submission : 2011-08-09
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-04
Pay. Date : 2013-09-25
DMF Number : 5046
Submission : 1983-06-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-08-16
Pay. Date : 2019-06-24
DMF Number : 33740
Submission : 2019-05-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16718
Submission : 2003-07-18
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-07-26
Pay. Date : 2024-06-10
DMF Number : 38878
Submission : 2023-09-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-03-02
Pay. Date : 2018-02-20
DMF Number : 5261
Submission : 1984-01-23
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-10-18
Pay. Date : 2024-09-19
DMF Number : 40427
Submission : 2024-09-04
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10232
Submission : 1993-03-06
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5429
Submission : 1984-07-09
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3715
Submission : 1980-02-11
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Calcium Folinate Hydrate, Amorphous
Certificate Number : CEP 2013-176 - Rev 02
Status : Valid
Issue Date : 2024-04-02
Type : Chemical
Substance Number : 978
Certificate Number : CEP 1997-051 - Rev 10
Status : Valid
Issue Date : 2024-03-06
Type : Chemical
Substance Number : 978
Certificate Number : CEP 2004-009 - Rev 04
Status : Valid
Issue Date : 2024-04-15
Type : Chemical
Substance Number : 978
Certificate Number : R1-CEP 2011-370 - Rev 00
Status : Valid
Issue Date : 2019-07-26
Type : Chemical
Substance Number : 978
Certificate Number : R1-CEP 1996-055 - Rev 08
Status : Valid
Issue Date : 2023-05-19
Type : Chemical
Substance Number : 978
Registration Number : 221MF10021
Registrant's Address : Via Figino 6,6917 Barbengo/Lugano, Switzerland
Initial Date of Registration : 2009-01-28
Latest Date of Registration : 2018-01-10
Registration Number : 227MF10147
Registrant's Address : 6, rue des Iles CH-2108 COUVET Switzerland
Initial Date of Registration : 2015-05-20
Latest Date of Registration : 2015-05-20
Registration Number : 218MF10352
Registrant's Address : Weisshausmatte CH-6460 Altdorf Switzerland
Initial Date of Registration : 2006-03-17
Latest Date of Registration : 2011-08-19
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Leucovorin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Leucovorin, including repackagers and relabelers. The FDA regulates Leucovorin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Leucovorin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Leucovorin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Leucovorin supplier is an individual or a company that provides Leucovorin active pharmaceutical ingredient (API) or Leucovorin finished formulations upon request. The Leucovorin suppliers may include Leucovorin API manufacturers, exporters, distributors and traders.
click here to find a list of Leucovorin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Leucovorin DMF (Drug Master File) is a document detailing the whole manufacturing process of Leucovorin active pharmaceutical ingredient (API) in detail. Different forms of Leucovorin DMFs exist exist since differing nations have different regulations, such as Leucovorin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Leucovorin DMF submitted to regulatory agencies in the US is known as a USDMF. Leucovorin USDMF includes data on Leucovorin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Leucovorin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Leucovorin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Leucovorin Drug Master File in Japan (Leucovorin JDMF) empowers Leucovorin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Leucovorin JDMF during the approval evaluation for pharmaceutical products. At the time of Leucovorin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Leucovorin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Leucovorin Drug Master File in Korea (Leucovorin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Leucovorin. The MFDS reviews the Leucovorin KDMF as part of the drug registration process and uses the information provided in the Leucovorin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Leucovorin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Leucovorin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Leucovorin suppliers with KDMF on PharmaCompass.
A Leucovorin CEP of the European Pharmacopoeia monograph is often referred to as a Leucovorin Certificate of Suitability (COS). The purpose of a Leucovorin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Leucovorin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Leucovorin to their clients by showing that a Leucovorin CEP has been issued for it. The manufacturer submits a Leucovorin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Leucovorin CEP holder for the record. Additionally, the data presented in the Leucovorin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Leucovorin DMF.
A Leucovorin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Leucovorin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Leucovorin suppliers with CEP (COS) on PharmaCompass.
A Leucovorin written confirmation (Leucovorin WC) is an official document issued by a regulatory agency to a Leucovorin manufacturer, verifying that the manufacturing facility of a Leucovorin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Leucovorin APIs or Leucovorin finished pharmaceutical products to another nation, regulatory agencies frequently require a Leucovorin WC (written confirmation) as part of the regulatory process.
click here to find a list of Leucovorin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Leucovorin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Leucovorin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Leucovorin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Leucovorin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Leucovorin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Leucovorin suppliers with NDC on PharmaCompass.
Leucovorin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Leucovorin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Leucovorin GMP manufacturer or Leucovorin GMP API supplier for your needs.
A Leucovorin CoA (Certificate of Analysis) is a formal document that attests to Leucovorin's compliance with Leucovorin specifications and serves as a tool for batch-level quality control.
Leucovorin CoA mostly includes findings from lab analyses of a specific batch. For each Leucovorin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Leucovorin may be tested according to a variety of international standards, such as European Pharmacopoeia (Leucovorin EP), Leucovorin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Leucovorin USP).
LOOKING FOR A SUPPLIER?